The modern approach to intravesical therapy of chronic cystitis
O.D. Nikitin – Bogomolets National Medical University Kyiv
The difficult of treating patients with chronic recurrent cystitis are caused by various factors like virulence of uropathogenic Escherichia coli, and the state of the local resistance of the bladder mucosa and their interaction. Instilan instillations in the treatment of patients with chronic cystitis led to a pronounced positive dynamics of clinical 95% of patients, as well as to reduce the number of recurrences of cystitis more than 2 times, which greatly improved the quality of life of patients. The results allow us to recommend the use of intravesical sodium hyaluronate for the treatment of various forms of chronic cystitis.
Key words: chronic cystitis, intravesical therapy, instilan.
Avant d'utiliser le médicament proposé sur ce site d'information il est strictement recommendé de consulter votre médecin et prendre connaissance de cette notice.
L'information sur le médicament destiné à l'activité médicale des spécialistes en protection de la santé. INSTYLAN 0,16% est un gel transparent, sans couleurs, contenant l'acide hyaluronique d'origine non animale, stéril avec un ph physiologique.
INSTYLAN 0,16% a une approbation de la ІІa classe du produit à destination médicale. Sertificat de conformité de l'Union européenne. Numéro d'enregistrement: DD 60107286 0001. Fabricant: Diaco Biofarmaceutici S.R.L. Via Flavia 124, 34147, Trieste, Italy. E-mail: info@diaco.it. www.diaco.it.
